Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome

por Davies MJ, Merton KW, Vijapurkar U, Balis DA, Desai M
Publicado 2017

Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies

por Fernandez RC, Moore VM, Van Ryswyk EM, Varcoe TJ, Rodgers RJ, March WA, Moran LJ, Avery JC, McEvoy RD, Davies MJ
Publicado 2018